SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,944.28 -12.99
( -0.02%)

Global Indices

Nasdaq

53,227.35 -353.64
(-0.66%)

Dow Jones

7,711.10 -21.66
(-0.28%)

Hang Seng

66,431.13 119.20
(0.18%)

Nikkei 225

10,824.26 31.76
(0.29%)

Forex

USD-INR

95.47 -0.01
(-0.01%)

EUR-INR

110.57 -0.67
(-0.60%)

GBP-INR

129.19 -0.55
(-0.42%)

JPY-INR

0.60 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

337.9869392

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

44.91

45237.67

EPS(TTM)

Face Value()

Div & Yield %

80.61

0.78

Back

Secmark Consultancy reports consolidated net loss of Rs 0.19 crore in the June 2026 quarter

Aug 13,2026

Net Loss of Secmark Consultancy reported to Rs 0.19 crore in the quarter ended June 2026 as against net loss of Rs 0.90 crore during the previous quarter ended June 2025. Sales rose 55.64% to Rs 10.35 crore in the quarter ended June 2026 as against Rs 6.65 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	10.35	6.65	56
OPM %	9.86	-5.56	-
PBDT	1.20	-0.15	LP
PBT	-0.25	-1.18	79
NP	-0.19	-0.90	79

76,944.28 -12.99 ( -0.02%)

53,227.35 -353.64 (-0.66%)

7,711.10 -21.66 (-0.28%)

66,431.13 119.20 (0.18%)

10,824.26 31.76 (0.29%)

95.47 -0.01 (-0.01%)

110.57 -0.67 (-0.60%)

129.19 -0.55 (-0.42%)

0.60 0.00 (-0.48%)